Medical Condition News

RSS

Rutgers expert shares holiday tips for caregivers of loved ones with Alzheimer’s and dementia

Family caregivers and people with dementia or Alzheimer's disease are at risk for increased stress during the holidays – but holiday visits can be a joyous time with adjusted expectations and careful planning.

9 Dec 2019

Treating the whole patient essential for older people with cardiovascular disease

Geriatric conditions such as frailty and cognitive impairments may inadvertently worsen when older patients are treated in cardiac intensive care units - even as they receive excellent care for their heart attack, heart failure, valvular heart disease or pulmonary embolism, according to a new scientific statement from the American Heart Association, published today in the Association's premier journal Circulation.

9 Dec 2019

$Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission$

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission.

8 Dec 2019

Methamphetamine undermines success in treatment for opioid-use disorder

Judith Tsui, a UW Medicine clinician specializing in addiction treatment, was seeing more and more patients she was treating for opioid-use disorder also using methamphetamines, a powerful, highly addictive stimulant that affects the central nervous system.

8 Dec 2019

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients' bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

8 Dec 2019

Irutinib-based therapy provides superior clinical outcomes in majority of CLL patients

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912.

8 Dec 2019

Study may provide novel therapeutic approach for Huntington's, Parkinson's diseases

Insights from their study may provide a novel therapeutic approach for diseases such as Huntington's and Parkinson's.

8 Dec 2019

Identifying the type of pain in adults with sickle cell disease may help improve treatment

Identifying the type of pain an adult with sickle cell disease experiences may be useful in improving treatment, according to a new study by researchers at Yale Cancer Center and Smilow Cancer Hospital.

8 Dec 2019

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.

8 Dec 2019

The role of adenosine in neurodegeneration and brain regeneration

The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis.

8 Dec 2019

Multiplexed C dots track different cancer targets to improve treatment

For more than a decade, researchers have used glowing nanoparticles called Cornell dots, or C dots, to illuminate cancer cells, target tumors and even induce cell death.

6 Dec 2019

Pilot clinical trial tests new treatment for type 1 diabetes

Type 1 diabetes is a chronic condition in which the body's own immune system attacks and destroys beta cells in the pancreas. Once the beta cells are destroyed, the pancreas can no longer produce insulin. Currently, there is no cure for T1D and treatment focuses on managing blood sugar levels.

6 Dec 2019

Researchers discover potent next generation of drugs to fight leukemia and lymphoma

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children.

6 Dec 2019

Cancer patients report less dry mouth after receiving acupuncture treatment

After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Texas MD Anderson Cancer Center.

6 Dec 2019

Clinical trial demonstrates safety and effectiveness of oral drug to treat NASH

Patients with nonalcoholic steatohepatitis, a chronic liver disease and a leading cause for liver transplantation in the U.S., currently lack an approved drug therapy, but this may soon change.

6 Dec 2019

Study sheds light on how ‘junk DNA’ affects inherited cancer risk

A person’s risk of developing cancer is affected by genetic variations in regions of DNA that don’t code for proteins, previously dismissed as ‘junk DNA’, according to new research published in the British Journal of Cancer today (Friday).

6 Dec 2019

Scientists test repurposed drugs for treatment of rare eye condition

Fight for Sight is funding scientists from the University of Aberdeen to test two repurposed drugs for the treatment of the rare eye condition aniridia, which causes blindness.

6 Dec 2019

Cancer in the eye does not always develop into central nervous system lymphoma

Researchers at Okayama University report in the Journal of clinical and experimental hematopathology that primary intraocular lymphoma, a cancer in the eye, does not always develop into central nervous system lymphoma.

6 Dec 2019

Mologic starts major clinical trial to validate point-of-care COPD exacerbation alert system

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company’s urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .

6 Dec 2019

$Novel agent opens up new treatment option for patients with refractory myeloma$

Novel agent opens up new treatment option for patients with refractory myeloma

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria participated.

6 Dec 2019

1
2
3
4
...
4196
Next

Medical Condition News

Rutgers expert shares holiday tips for caregivers of loved ones with Alzheimer’s and dementia

Treating the whole patient essential for older people with cardiovascular disease

Experimental immunotherapy can put patients with relapsed or refractory lymphoma into remission

Methamphetamine undermines success in treatment for opioid-use disorder

Adding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

Irutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Study may provide novel therapeutic approach for Huntington's, Parkinson's diseases

Identifying the type of pain in adults with sickle cell disease may help improve treatment

UM Medicine launches new centers in Maryland to treat adults with neurodevelopmental disabilities

The role of adenosine in neurodegeneration and brain regeneration

Multiplexed C dots track different cancer targets to improve treatment

Pilot clinical trial tests new treatment for type 1 diabetes

Researchers discover potent next generation of drugs to fight leukemia and lymphoma

Cancer patients report less dry mouth after receiving acupuncture treatment

Clinical trial demonstrates safety and effectiveness of oral drug to treat NASH

Study sheds light on how ‘junk DNA’ affects inherited cancer risk

Scientists test repurposed drugs for treatment of rare eye condition

Cancer in the eye does not always develop into central nervous system lymphoma

Mologic starts major clinical trial to validate point-of-care COPD exacerbation alert system

Novel agent opens up new treatment option for patients with refractory myeloma

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Applying a Proteomics-based Approach to the Clinic

Proteomics & DIA Mass Spectroscopy in Neurodegenerative Disease Research

Latest News